Novo Nordisk | NVO - 债务利息支出

金融业

DKK

DKK 90.92B

现金及等价物

DKK 21.13B

DKK 2.66B

DKK 31.89B

DKK 36.54B

DKK 146.38B

股息收益率

DKK 3.76

DKK 5.25B

DKK 37.37B

DKK 54.39K

EPS每股收益

DKK 0.96

股本和储备

DKK 33.81B

DKK 83.23B

债务利息支出

DKK 82.1M

DKK 6.05B

DKK 18.61B

DKK 156.11B

DKK 3.26B

DKK 6.96B

DKK 5.25B

普通股股本

DKK 4.43B

9.94

DKK 62.17B

DKK 12.13B

销售和管理费用

DKK 2.54B

DKK 51.35B

贸易债权人

DKK 2.23B

应收帐款人

DKK 17.56B

	债务利息支出	更改		日
ANI Pharmaceuticals	USD 3.64M		775K	2026-06
Aurora Cannabis	CAD 230K		1.88M	2026-03
Bausch Health Companies	USD 402M		5M	2026-03
Bristol-Myers Squibb	USD 407M		4M	2026-06
Canopy Growth	CAD 12.31M		4.97M	2026-03
Corcept Therapeutics	USD 888.7M		73.82M	2026-06
Drreddys Laboratories	INR 1.06B		113M	2026-03
Eli Lilly	USD 114.7M		134.3M	2025-09
GlaxoSmithKline	GBP 121M		46M	2026-06
Merck	USD 525M		46M	2026-06
Nektar Therapeutics	USD 7.94M		1.83M	2026-03
Novartis	USD 462M		119M	2026-06
Novo Nordisk	DKK 1.5B		28M	2026-06
Pacira	USD 3.62M		77K	2026-06
Perrigo	USD 7.61B		373.8M	2026-06
Phibro Animal Health	USD 11.91M		191K	2025-12
Prestige Brands	USD 13.94M		2.52M	2026-06
Sanofi	EUR 287M		109M	2026-06
Supernus Pharmaceuticals	USD 910K		278K	2023-06
Zoetis	USD 61M		1000K	2026-06